Video ophthalmoscope for Intracranial Hypertension

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Intracranial HypertensionVideo ophthalmoscope - Device
Eligibility
Any Age
All Sexes
What conditions do you have?
Select

Study Summary

This trial will test a new, non-invasive way to measure pressure inside the skull, which could be helpful for patients with certain conditions.

Eligible Conditions
  • Intracranial Hypertension

Treatment Effectiveness

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: Participants in the Healthy Control and Intra-Group Verification arms will be enrolled for one day. Transfer Function Estimation Subjects will be enrolled for up to 14 days.

Day 14
The study will look at whether retinal video-recordings can be used to help estimate intracranial pressure.

Trial Safety

Trial Design

3 Treatment Groups

Transfer Function Estimation
1 of 3
Healthy Controls
1 of 3
Intra-Group Verification
1 of 3

Experimental Treatment

90 Total Participants · 3 Treatment Groups

Primary Treatment: Video ophthalmoscope · No Placebo Group · N/A

Transfer Function Estimation
Device
Experimental Group · 1 Intervention: Video ophthalmoscope · Intervention Types: Device
Healthy Controls
Device
Experimental Group · 1 Intervention: Video ophthalmoscope · Intervention Types: Device
Intra-Group Verification
Device
Experimental Group · 1 Intervention: Video ophthalmoscope · Intervention Types: Device

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: participants in the healthy control and intra-group verification arms will be enrolled for one day. transfer function estimation subjects will be enrolled for up to 14 days.

Who is running the clinical trial?

University of MinnesotaLead Sponsor
1,255 Previous Clinical Trials
1,483,808 Total Patients Enrolled
Igor Nestrasil, MD, PhDPrincipal InvestigatorUniversity of Minnesota

Eligibility Criteria

Age Any Age · All Participants · 2 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you: